Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Find the latest information on COVID-19, monkeypox, and the flu vaccine

Parkinson’s Disease

Click to See Chart

What Is Parkinson's Disease?

Parkinson's disease is a chronic, progressive neurological disorder. It is due to damage or death of dopamine-producing cells in the brain, leading to a decrease in the neurotransmitter called Dopamine. Dopamine is important for motor function.

PODCAST

When in Doubt - Exercise
Listen to a conversation on exercise and Parkinson's disease with Helen Bronte-Stewart, MD, MS.

Get Podcast (iTunes)

What Is Parkinson's Disease?

Parkinson's disease is a chronic, progressive neurological disorder. It is due to damage or death of dopamine-producing cells in the brain, leading to a decrease in the neurotransmitter called Dopamine. Dopamine is important for motor function.

Condition Spotlight

Patient Stories Parkinson’s Patient Spreads Awareness for the Disease with Push-Ups
New Technology Used to Treat Parkinson's Disease
New Technology Used to Treat Parkinson's Disease Play Video | 2:21
Stanford Hospital's Jaimie Henderson, MD, on Parkinson's Disease
Stanford Hospital's Jaimie Henderson, MD, on Parkinson's Disease Play Video | 3:22
Press Release From the Inside Out: Deep Brain Stimulation Designed to Control Parkinson's Disease

Clinical Trials for Parkinson's Disease

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Clinics for Parkinson's Disease